IBTA Stock Analysis: Ibotta | NYSE
Software - Application | NYSE, USA | Market Cap: 1.402m USD | 12M Return: 112.6% | US4510511060 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 17.3M
Qual. Beats: 0
Rev. Trend: 11.3%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
Seasonality 2.4 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Ibotta, Inc. (IBTA) is a U.S.-based technology company that operates a digital promotion platform connecting consumer packaged goods (CPG) brands with consumers through a network of publishers. Its core offering, the Ibotta Performance Network (IPN), distributes brand-funded promotions across direct-to-consumer mobile, web, and browser extension properties, as well as third-party publisher sites. Service formats include display ads, tiles, sponsored offers, newsletters, and feature placements, with a dedicated product suite called LiveLift aimed at driving brand sales. The company was incorporated in 2011 in Denver, Colorado, and was formerly known as Zing Enterprises, Inc. before adopting the Ibotta name in 2012.
The company sits within the digital advertising sub-industry, operating a performance-based marketing model in which brands pay for measurable consumer engagement (such as coupon redemptions or offer activations) rather than traditional impression-based advertising. This affiliate- or cashback-style approach is commonly used by CPG advertisers seeking measurable return on promotional spend.
- IPN publisher network expansion drives redemption revenue growth
- CPG brand ad budget cuts pressure promotion spend
- Competition from Fetch and Rakuten pressures take rates
| Net Income: 3.12m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.16 > 0.02 and ΔFCF/TA 4.75 > 1.0 |
| NWC/Revenue: 42.43% < 20% (prev 70.67%; Δ -28.24% < -1%) |
| CFO/TA 0.19 > 3% & CFO 93.4m > Net Income 3.12m |
| Net Debt (-125.0m) to EBITDA (7.25m): -17.25 < 3 |
| Current Ratio: 1.67 > 1.5 & < 3 |
| Outstanding Shares: last quarter (23.3m) vs 12m ago -24.68% < -2% |
| Gross Margin: 78.15% > 18% (prev 80.71%; Δ -2.56% > 0.5%) |
| Asset Turnover: 67.27% > 50% (prev 61.86%; Δ 5.41% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.31 (Total Current Assets 377.4m - Total Current Liabilities 225.6m) / Total Assets 494.1m |
| B: -0.31 (Retained Earnings -151.9m / Total Assets 494.1m) |
| C: -0.01 (EBIT TTM -3.56m / Avg Total Assets 531.8m) |
| D: 0.93 (Book Value of Equity 238.3m / Total Liabilities 255.8m) |
| Altman-Z'' = 1.95 = BBB |
| DSRI: 1.02 (Receivables 221.5m/212.8m, Revenue 357.7m/352.2m) |
| GMI: 1.03 (GM 80.71% / 78.15%) |
| AQI: 1.15 (AQ_t 0.17 / AQ_t-1 0.15) |
| SGI: 1.02 (Revenue 357.7m / 352.2m) |
| TATA: -0.18 (NI 3.12m - CFO 93.4m) / TA 494.1m) |
| Beneish M = -2.89 (Cap -4..+1) = A |
As of November 11, 2026, the stock is trading at USD 60.30 with a total of 595,206 shares traded. Over the past week, the price has changed by -0.08%, over one month by +40.36%, over three months by +66.62% and over the past year by +112.62%.
Current recommended Stop Loss: 56.30 (which is 6.6% or 1.2 ATR below the current price).
Ibotta has received a consensus analysts rating of 2.78. Therefore, it is recommended to hold IBTA.
- StrongBuy: 0
- Buy: 1
- Hold: 6
- Sell: 1
- StrongSell: 1
| Analysts Target Price | 38.4 | -36.3% |
P/E Forward = 153.8462
P/S = 4.0845
P/B = 4.1761
Revenue TTM = 357.7m USD
EBIT TTM = -3.56m USD
EBITDA TTM = 7.25m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 24.9m USD (from shortLongTermDebtTotal, last quarter) (leases 25.1m already included)
Net Debt = -125.0m USD (calculated: Debt 24.9m - CCE 149.9m)
Enterprise Value = 1.28b USD (1.40b + Debt 24.9m - CCE 149.9m)
Interest Coverage Ratio = unknown (Ebit TTM -3.56m / Interest Expense TTM 0.0)
EV/FCF = 15.67x (Enterprise Value 1.28b / FCF TTM 81.5m)
FCF Yield = 6.38% (FCF TTM 81.5m / Enterprise Value 1.28b)
FCF Margin = 22.77% (FCF TTM 81.5m / Revenue TTM 357.7m)
Net Margin = 0.87% (Net Income TTM 3.12m / Revenue TTM 357.7m)
Gross Margin = 78.15% ((Revenue TTM 357.7m - Cost of Revenue TTM 78.2m) / Revenue TTM)
Gross Margin QoQ = 79.85% (prev 78.42%)
Tobins Q-Ratio = 2.58 (Enterprise Value 1.28b / Total Assets 494.1m)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 24.9m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -2.81m (EBIT -3.56m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.67 (Total Current Assets 377.4m / Total Current Liabilities 225.6m)
Debt / Equity = 0.10 (Debt 24.9m / totalStockholderEquity, last quarter 238.3m)
Debt / EBITDA = -17.25 (Net Debt -125.0m / EBITDA 7.25m)
Debt / FCF = -1.53 (Net Debt -125.0m / FCF TTM 81.5m)
Total Stockholder Equity = 254.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.59% (Net Income 3.12m / Total Assets 494.1m)
RoE = 1.23% (Net Income TTM 3.12m / Total Stockholder Equity 254.1m)
RoCE = -1.33% (EBIT -3.56m / Capital Employed (Total Assets 494.1m - Current Liab 225.6m))
RoIC = -1.12% (negative operating profit) (NOPAT -2.81m / Invested Capital 250.6m)
WACC = 9.91% (E(1.40b)/V(1.43b) * Re(10.09%) + D(24.9m)/V(1.43b) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 10.09% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -88.05 | Cagr: -11.34%
[DCF] Terminal Value 73.08% ; FCFF base≈75.6m ; Y1≈86.7m ; Y5≈127.6m
[DCF] Fair Price = 80.87 (EV 1.50b - Net Debt -125.0m = Equity 1.63b / Shares 20.1m; r=9.91% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.41 | # QB: 0
Revenue Correlation: 11.29 | Revenue CAGR: 0.54% | SUE: 2.00 | # QB: 1
EPS current Quarter (2027-03-31): EPS=0.32 | Chg30d=+18.87% | Revisions=+25% | Analysts=2
EPS current Year (2026-12-31): EPS=1.82 | Chg30d=+14.00% | Revisions=+17% | GrowthEPS=+6.3% | GrowthRev=+7.1%
EPS next Year (2027-12-31): EPS=2.13 | Chg30d=+13.27% | Revisions=+50% | GrowthEPS=+17.4% | GrowthRev=+6.6%
[Analyst] Revisions Ratio: +50% (up=6, down=1)